Trials / Completed
CompletedNCT01023789
ABSORB EXTEND Clinical Investigation
ABSORB EXTEND Clinical Investigation: A Continuation in the Clinical Evaluation of the ABSORB Bioresorbable Vascular Scaffold (BVS) System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 812 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The ABSORB EXTEND trial is to continue the assessment of the safety and performance of the ABSORB Bioresorbable Vascular Scaffold (BVS) System ABSORB BVS is currently in development at Abbott Vascular.
Conditions
- Myocardial Ischemia
- Coronary Artery Stenosis
- Coronary Disease
- Coronary Artery Disease
- Coronary Restenosis
- Cardiovascular Disease
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ABSORB BVS | Absorb Bioresorbable Vascular Scaffold (BVS) System implantation |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2009-12-02
- Last updated
- 2018-02-14
- Results posted
- 2017-12-18
Locations
56 sites across 25 countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, India, Israel, Italy, Japan, Malaysia, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom
Source: ClinicalTrials.gov record NCT01023789. Inclusion in this directory is not an endorsement.